A detailed history of Xtx Topco LTD transactions in Cytokinetics Inc stock. As of the latest transaction made, Xtx Topco LTD holds 9,871 shares of CYTK stock, worth $457,619. This represents 0.04% of its overall portfolio holdings.

Number of Shares
9,871
Holding current value
$457,619
% of portfolio
0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$51.22 - $60.16 $505,592 - $593,839
9,871 New
9,871 $521,000
Q4 2023

Feb 13, 2024

SELL
$26.88 - $83.49 $387,555 - $1.2 Million
-14,418 Reduced 77.53%
4,178 $348,000
Q3 2023

Nov 13, 2023

BUY
$29.46 - $36.61 $547,838 - $680,799
18,596 New
18,596 $547,000
Q2 2022

Aug 15, 2022

BUY
$33.93 - $48.92 $570,397 - $822,394
16,811 New
16,811 $661,000

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.36B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.